Nuvation Bio Inc. (NUVB)
NUVB trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$4.72
-3.67% on the day
Market cap
$1.7B
Small cap
Revenue · 2025
$62.9M
+699.0% on 2024
Net income · 2025
-$204.6M
-325.3% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | NUVB on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2020 |
| SEC CIK | 0001811063 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $62.9M |
| Net income | -$204.6M |
| Operating income | -$213.1M |
| Net margin | -325.3% |
| Operating margin | -338.7% |
| Revenue growth | +699.0% |
| Cash | $164.1M |
| Total assets | $594.8M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 26.3× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-06-29 |
| Latest annual report | 10-K | 2026-03-02 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report | 8-K | 2026-08-06 |
| Latest proxy | DEFA14A | 2026-04-21 |
Source: SEC EDGAR submissions feed, 398 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -3.6% |
| 1 month | -19.2% |
| 3 months | -16.9% |
| Year to date | -47.7% |
| 1 year | +27.3% |
| From 52-week high | -50.9% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ZBIO | Zenas BioPharma Inc. | $25.16 | -4.70% | $1.6B |
| ANIP | ANI Pharmaceuticals Inc. | $70.84 | -3.74% | $1.6B |
| MRVI | Maravai LifeSciences Holdings Inc. | $6.53 | -7.51% | $1.7B |
| SEPN | Septerna Inc. | $36.41 | -3.05% | $1.7B |
| BHVN | Biohaven Ltd. Common Shares | $11.42 | -3.30% | $1.7B |
| GPCR | Structure Therapeutics Inc. | $22.31 | -6.69% | $1.6B |
| OCUL | Ocular Therapeutix Inc. | $7.24 | -4.23% | $1.6B |
| BRVE | Braveheart Bio Inc. | $19.33 | -5.06% | $1.7B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier